✦ LIBER ✦

Results of a proof-of-concept, dose-finding, double-blind, placebo-controlled study of RX-10100 (Serdaxin®) in subjects with major depressive disorder

✍ Scribed by Robert Riesenberg,Joshua Rosenthal,Leslie Moldauer…

Book ID: 118296831
Publisher: Springer
Year: 2011
Tongue: English
Weight: 203 KB
Volume: 221
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-011-2604-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Escitalopram for Severe Asthma and Major

Escitalopram for Severe Asthma and Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study

✍ E. Sherwood Brown; Christina Howard; David A. Khan; Thomas J. Carmody 📂 Article 📅 2012 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 224 KB

A double-blind dose-finding study of rol

A double-blind dose-finding study of rolipram in patients with major depressive disorder

✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re

Deramciclane in the treatment of general

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

✍ Hannu Naukkarinen; Roope Raassina; Jukka Penttinen; Antti Ahokas; Riitta Jokinen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A Randomized Trial of Citalopram versus

A Randomized Trial of Citalopram versus Placebo in Outpatients with Asthma and Major Depressive Disorder: A Proof of Concept Study

✍ E. Sherwood Brown; Luis Vigil; David A. Khan; Joshua D.M. Liggin; Thomas J. Carm 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Paroxetine controlled-release formulatio

Paroxetine controlled-release formulation in the treatment of major depressive disorder: A randomized, double-blind, placebo-controlled study in Japan and Korea

✍ Teruhiko Higuchi; Jin Pyo Hong; Hee-Yeon Jung; Yoshinori Watanabe; Taro Kunitomi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

A randomised, double-blind, placebo cont

A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)

✍ David S. Baldwin; Henrik Loft; Marianne Dragheim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 405 KB